Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Magnetic resonance imaging (MRI) signal enhancement via proton relaxation modulation refers to the use of various agents or mechanisms to alter the relaxation properties of protons (primarily water protons) in tissues, thereby improving image contrast and diagnostic utility. This process is central to MRI technology, as it enables differentiation between tissue types and detection of abnormalities. Techniques involve using contrast agents like gadolinium complexes and iron oxide nanoparticles, as well as methods like Chemical Exchange Saturation Transfer (CEST) and T1rho imaging. The aim is to modulate the spin-lattice (T1) and spin-spin (T2) relaxation times of water protons to enhance signal intensity and contrast in MRI images.
Modulation of T1 and T2 relaxation times of water protons in tissues using paramagnetic or superparamagnetic contrast agents, chemical exchange saturation transfer (CEST), or exchange-mediated orientational randomization to enhance MRI signal and improve image contrast.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Magnetic Resonance Imaging Signal Enhancement via Proton Relaxation Modulation.